Yunlong Richard Cao on X: It's critical to test how these RBD hotspots could combine to achieve max immune evasion without losing affinity to ACE2. After careful consideration, besides the emerging K478R/F456L

$ 20.50

4.9
(279)
In stock
Description

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Thread by @yunlong_cao on Thread Reader App – Thread Reader App

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Thread by @yunlong_cao on Thread Reader App – Thread Reader App

Yunlong Richard Cao (@yunlong_cao) / X

PDF) Underlying driving forces of the SARS-CoV-2 evolution: immune evasion and ACE2 binding affinity

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity

AI-driven prediction of SARS-CoV-2 variant binding trends from atomistic simulations

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Yunlong Richard Cao (@yunlong_cao) / X